CPRA >98% form for highly sensitized candidates removed
All candidates with a CPRA above 98% continue to be prioritized on the match appropriately.
All candidates with a CPRA above 98% continue to be prioritized on the match appropriately.
Transplant hospitals will no longer be required to obtain signatures and update candidate registrations when a candidate’s CPRA is above 98%. There are no changes needed for OPOs.
Patient care will not be impacted during this time.
Twenty-two UNOS staff members presented research from 42 studies at the 2023 American Transplant Congress, addressing topics including social determinants of health, offer-acceptance practices, and the impacts of allocation-policy changes.
These changes were approved by the OPTN Board of Directors at their June 26, 2023 meeting.
Changes to security personnel requirements and reporting to be implemented following policy changes approved by the OPTN Board of Directors.